|
PRESS RELEASES
Contacts: John J. Viscogliosi, CEO, Raymedica, Inc. (952) 885-0500
RAYMEDICA HIRES NEW VICE PRESIDENT OF SALES & MARKETING AND VICE
PRESIDENT OF R&D/OPERATIONS
Minneapolis, MN: May 3, 2005 - Raymedica Inc., a medical device developer
and manufacturer, announced today that Jon R. Luedke has joined Raymedica
as Vice President of Sales & Marketing and Steven J. Seme as Vice
President of R&D/Operations.
John J. Viscogliosi, Chairman and CEO, “In order to achieve the
goals Raymedica is striving for, it’s necessary to have experienced
leader with strong spine industry backgrounds join the team. Jon Luedke
joins Raymedica with over 19 years of senior management, sales, marketing,
and medical industry experience. Steven Seme provides us with beneficial
product development leadership and operations expertise. Both Jon and
Steven have a strong background in emerging technologies and relationships
with key opinion leaders in the spine area. I am very pleased to welcome
Jon and Steven to our executive team. They bring a wealth of experience
and knowledge to an already talented group.”
Prior to joining Raymedica Jon Luedke directed Zimmer Spine’s
OrthoBiologic Business unit managing the areas of business planning,
strategy development, and new product planning, sales and distribution.
Mr. Luedke has also served in various executive positions within Fortune
500 companies and start-up companies where he was responsible for all
marketing, strategic development, and financial activities. Steven Seme
has over 10 years of extensive implantable medical device experience.
His knowledge spans the technical, operational and leadership side of
both start-up and large global companies in the areas of diagnostic,
orthopedic and spine. Most recently, Mr. Seme directed, from product
concept to market release, several spinal device projects and key business
development teams as Director of Product Development at Zimmer Spine.
“I look forward to making significant contributions to Raymedica,
especially the execution of the strategic sales & marketing plan.”
said Jon Luedke. “The company’s vision to be the leader
in non-fusion technology is highly achievable with the growing need
for this technology.” Steven Seme adds, “Joining a company
that is not only the first to market, but the pioneer of the nucleus
replacement market and possesses a strong patent portfolio makes Raymedica
a company with unlimited potential.”
About Raymedica, Inc.
Raymedica develops, manufactures and markets medical device systems
designed to treat patients with degenerative disc disease that have
not responded to non-surgical treatment. Raymedica pioneered and is
the scientific, clinical and regulatory leader in the nucleus replacement
segment of the non-fusion spine market. Raymedica devices have been
used in more than 3,400 procedures globally. Raymedica’s products
are currently available worldwide, but are limited to investigational
use only in the United States.
For more information, visit the Company's website at: http://www.raymedica.com.
> Back to Press Releases
|
